LSA
ITOS

Leonteq Securities AG’s iTeos Therapeutics ITOS Stock Holding History

Leonteq Securities AG’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000
Closed -$15.4K – 1289
2024
Q4 		$15.4K Hold
2,000
– – ﹤0.01% 1008
2024
Q3 		$20.4K Hold
2,000
– – ﹤0.01% 907
2024
Q2 		$29.7K Hold
2,000
– – ﹤0.01% 866
2024
Q1 		$27.3K Hold
2,000
– – ﹤0.01% 876
2023
Q4 		$21.9K Buy
2,000
+800
+67% +$7.93K ﹤0.01% 927
2023
Q3 		$13.1K Hold
1,200
– – ﹤0.01% 990
2023
Q2 		$15.9K Buy
1,200
+400
+50% +$5.7K ﹤0.01% 982
2023
Q1 		$10.9K Buy
+800
New +$14.3K ﹤0.01% 1009

Other funds holding ITOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Leonteq Securities AG's ITOS Position: Q1 2025 in Review

Leonteq Securities AG sold out of iTeos Therapeutics (ITOS) in Q1 2025, closing a stake of 2,000 shares — an estimated $15.4K sold.

Leonteq Securities AG first reported a position in ITOS in Q1 2023 and held it in 8 quarters. The position peaked at $29.7K in Q2 2024. 131 funds tracked by Wall St. Rank hold ITOS as of Q1 2025.

  • Leonteq Securities AG reported no remaining iTeos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Leonteq Securities AG sold 2,000 iTeos Therapeutics shares in Q1 2025, an estimated $15.4K.
  • Leonteq Securities AG first reported a position in iTeos Therapeutics in Q1 2023 and held it in 8 quarters.
  • Leonteq Securities AG's iTeos Therapeutics position peaked at $29.7K in Q2 2024.
  • 131 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2025.

Based on Leonteq Securities AG's 13F filing for Q1 2025, filed 23 Feb 2026.